Market Growth Analysis: The global PDX models market is expected to reach to USD 167.6 Million by 2022 from USD 68.0 Million in 2016 at a CAGR of 16.7%. The growth of the overall Patient Derived Xenograft Models Market can be attributed to the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121598251 Objectives Of Study: 1. To define, describe, and measure the global Patient Derived Xenograft (PDX) models market by model type, tumor type, application, end user, and region 2. To provide detailed information regarding the major factors, such as drivers, restraints, growth opportunities, and challenges influencing the growth of the market 3. To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contri...
Latest Healthcare Industry Updates and Trends.